首页 › 基金 › ORBIMED ADVISORS LLC › GPCR
ORBIMED ADVISORS LLC 对 GPCR 的持仓历史
STRUCTURE THERAPEUTICS INC · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 GPCR(STRUCTURE THERAPEUTICS INC)2,209,400 股,市值约 US$118.6M,约占其申报组合的 2.38%,在其申报持仓中市值排名第 7 位。 ORBIMED ADVISORS LLC 最近 9 个申报季度中有 9 个季度披露了 GPCR 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 GPCR 的持仓演变
ORBIMED ADVISORS LLC 于 Q2 2024 首次披露 GPCR 持仓:125,000 股(约 US$4.9M)。 该持仓在 Q2 2026 达到峰值 2,209,400 股,市值约 US$118.6M。 在 9 次申报中,ORBIMED ADVISORS LLC 5 次增持、2 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 2,209,400 股、市值约 US$118.6M,环比增持 733,997 股。。 持仓曾出现大幅变动:Q3 2024 增持约 207% (随后一个季度股价下跌 38%)、Q4 2024 减持约 61% (随后一个季度股价下跌 36%)、Q2 2025 增持约 700% (随后一个季度股价上涨 35%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 125.00K | $4.91M | 新进 |
| Q3 2024 | 383.70K | $16.84M | 增持 |
| Q4 2024 | 150.00K | $4.07M | 减持 |
| Q1 2025 | 150.00K | $2.60M | 持有 |
| Q2 2025 | 1.20M | $24.87M | 增持 |
| Q3 2025 | 1.14M | $31.90M | 减持 |
| Q4 2025 | 1.16M | $80.80M | 增持 |
| Q1 2026 | 1.48M | $71.11M | 增持 |
| Q2 2026 | 2.21M | $118.58M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GPCR 与 13F 数据
GPCR(STRUCTURE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 GPCR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GPCR 的基金
- Avoro Capital Advisors LLC 6.56M 股 · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M 股 · $254.40M · Q2 2026
- BVF INC/IL 3.37M 股 · $180.70M · Q2 2026
- RTW INVESTMENTS, LP 1.61M 股 · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M 股 · $76.88M · Q2 2026
- Casdin 资本 1.18M 股 · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M 股 · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K 股 · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K 股 · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K 股 · $34.37M · Q2 2026
- Logos Global Management LP 500.00K 股 · $26.84M · Q2 2026
- Parkman Healthcare Partners LLC 485.66K 股 · $26.07M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held GPCR?
ORBIMED ADVISORS LLC has disclosed GPCR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is ORBIMED ADVISORS LLC's current position in GPCR?
As of Q2 2026, ORBIMED ADVISORS LLC holds 2.21M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $118.58M, representing 2.38% of its reported portfolio and ranking #7.
Has ORBIMED ADVISORS LLC been buying or selling GPCR?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in GPCR. The position peaked in Q2 2026 at 2.21M shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.